Investor Relations
Horizon’s Business Model

Horizon’s Business Model

We are global leaders in cell engineering, using our innovative gene editing and gene modulation technologies to provide our customers with the products and services they need to transform human health.

Our customers are the world’s leading academic institutions and global biopharmaceutical companies.  Our expertise and insight help them to gain a better understanding of disease and Horizon’s products and services are used applications in areas as varied as research, drug discovery, molecular diagnostics, and biomanufacturing.